Join the USDeN October 1, 2024 at 2:00 pm ET (11:00 am PT) for a special webinar: N-of-1 Trials to Promote Deprescribing. The featured presenter will be Dr. Parag Goyal of Weill Cornell Medicine. This webinar will outline the potential value of N-of-1 trials as an innovative strategy to promote deprescribing. More broadly, it will cover shared decision making. Dr. Goyal will also discuss suitability as a deprescribing intervention and key methodologic considerations. Additionally, he will present a case example. Register here.
Dr. Goyal is an Associate Professor of Medicine with joint appointments in the Division of Cardiology (as a member of the heart failure faculty). He is also part of the Division of General Internal Medicine (as a core member of the health services research faculty). Dr. Goyal is the Founding Director of the Heart Failure with Preserved Ejection Fraction Program. And he is the Director of the Cardiac Amyloidosis Program at Weill Cornell Medicine.
